These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 18031539)
1. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection. Hideko Tatakihara VL; Cecchini R; Borges CL; Malvezi AD; Graça-de Souza VK; Yamada-Ogatta SF; Rizzo LV; Pinge-Filho P FEMS Immunol Med Microbiol; 2008 Jan; 52(1):47-58. PubMed ID: 18031539 [TBL] [Abstract][Full Text] [Related]
2. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease. Borges CL; Cecchini R; Tatakihara VL; Malvezi AD; Yamada-Ogatta SF; Rizzo LV; Pinge-Filho P Immunol Lett; 2009 Mar; 123(1):38-45. PubMed ID: 19428550 [TBL] [Abstract][Full Text] [Related]
3. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169 [TBL] [Abstract][Full Text] [Related]
4. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297 [TBL] [Abstract][Full Text] [Related]
5. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide. Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334 [TBL] [Abstract][Full Text] [Related]
7. Macrophages in experimental Chagas' disease. Kuhn RE Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589 [TBL] [Abstract][Full Text] [Related]
8. Fighting the oxidative assault: the Trypanosoma cruzi journey to infection. Piacenza L; Alvarez MN; Peluffo G; Radi R Curr Opin Microbiol; 2009 Aug; 12(4):415-21. PubMed ID: 19616990 [TBL] [Abstract][Full Text] [Related]
9. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Savino W; Villa-Verde DM; Mendes-da-Cruz DA; Silva-Monteiro E; Perez AR; Aoki Mdel P; Bottasso O; Guiñazú N; Silva-Barbosa SD; Gea S Cytokine Growth Factor Rev; 2007; 18(1-2):107-24. PubMed ID: 17339126 [TBL] [Abstract][Full Text] [Related]
10. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Freire-de-Lima CG; Nascimento DO; Soares MB; Bozza PT; Castro-Faria-Neto HC; de Mello FG; DosReis GA; Lopes MF Nature; 2000 Jan; 403(6766):199-203. PubMed ID: 10646605 [TBL] [Abstract][Full Text] [Related]
11. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages. Ramos-Ligonio A; López-Monteon A; Talamás-Rohana P; Rosales-Encina JL Parasite Immunol; 2004 Oct; 26(10):409-18. PubMed ID: 15752118 [TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: in vivo evaluation of iron in skin employing X-ray fluorescence (XRF) in mouse strains that differ in their susceptibility to infection. Estevam M; Appoloni CR; Malvezi AD; Tatakihara VL; Panis C; Cecchini R; Rizzo LV; Pinge-Filho P FEMS Immunol Med Microbiol; 2012 Apr; 64(3):334-42. PubMed ID: 22136203 [TBL] [Abstract][Full Text] [Related]
13. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi. Cutrullis RA; Postan M; Petray PB; Corral RS Pathobiology; 2009; 76(4):170-80. PubMed ID: 19571606 [TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895 [TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection. Chessler AD; Unnikrishnan M; Bei AK; Daily JP; Burleigh BA J Immunol; 2009 Feb; 182(4):2288-96. PubMed ID: 19201883 [TBL] [Abstract][Full Text] [Related]
16. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. Zhang L; Tarleton RL J Infect Dis; 1999 Aug; 180(2):480-6. PubMed ID: 10395865 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-releasing indomethacin enhances susceptibility to Trypanosoma cruzi infection acting in the cell invasion and oxidative stress associated with anemia. Tatakihara VL; Malvezi AD; Panis C; Cecchini R; Zanluqui NG; Yamauchi LM; Martins MI; da Silva RV; Yamada-Ogatta SF; Rizzo LV; Martins-Pinge MC; Pinge-Filho P Chem Biol Interact; 2015 Feb; 227():104-11. PubMed ID: 25559858 [TBL] [Abstract][Full Text] [Related]
18. Deficient control of Trypanosoma cruzi infection in C57BL/6 mice is related to a delayed specific IgG response and increased macrophage production of pro-inflammatory cytokines. Pérez AR; Tamae-Kakazu M; Pascutti MF; Roggero E; Serra E; Revelli S; Bottasso O Life Sci; 2005 Sep; 77(16):1945-59. PubMed ID: 15916779 [TBL] [Abstract][Full Text] [Related]